Lidocaine Patch 5% Articles
US patent settlements of Xopenex and Lidoderm
30 May 2012
Endo buys US generics firm Qualitest for $1.2 billion
29 September 2010
Teikoku to help Eisai develop donepezil skin patch
16 March 2009
Opana growth drives Endo's profit up 15%
16 March 2009
Positive data for Endo's Lidoderm patch in OA
11 April 2005
Endo Pharma sees 2nd-qtr profits slump
26 July 2004
Endo net sales surge 49% in 2003
23 February 2004
Endo Pharma converting to own sales reps
22 September 2003
SkyePharma licenses key drugs to Endo
13 January 2003
Endo sales to reach $440M in fiscal 2003
6 January 2003
Showing 1-11 of 11 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
